Navigation Links
CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Decrease Pancreatic Cancer Tumor Blood Flow and Reduce Blood Vessel Density
Date:6/23/2011

CFAK-C4, reduced tumor growth in vivo in mouse pancreatic cancer cells by up to 60 percent, and CFAK-C4 combined with chemotherapy drug gemcitabine had a synergistic effect and led to 80 percent pancreatic cancer tumor reduction.  

The study also found that CFAK-C4 combined with gemcitabine had a prolonged effect on pancreatic tumor growth.  Two weeks after treatment, the tumor size in the previously treated group was approximately 75 percent smaller than the tumor in the control group. The researchers concluded that targeting FAK with small molecule inhibitors can be effectively used to develop potential oral-based cancer therapies.

"We continue to gain knowledge about the activity of our lead compound, CFAK-C4, and this most recent study furthers our understanding of FAK inhibitors and the potential of this compound," said H. Shep Wild, President and Chief Executive Officer of CureFAKtor Pharmaceuticals.  "CureFAKtor's proprietary FAK technology platform may represent a significant breakthrough in the treatment of most solid tumor cancers in that its unique mechanism of action disrupts the signaling of specific protein to protein binding between FAK and tumors."

Earlier this year, CureFAKtor received Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for CFAK-C4 in combination with gemcitabine for the treatment of pancreatic cancer, a disease with the lowest survival rate of any cancer and limited patient treatment options.

About Focal Adhesion Kinase (FAK)

Focal adhesion Kinase (FAK) is substantially over-expressed in many solid tumors. FAK operates by placing itself at the contact points between tumor cells and the extra cellular matrix that surrounds them. Studies by CureFAKtor and others found that in this role, FAK is an important facilitator for signals that cause tumor cells to survive, grow, and produce new blood vessels to sustain growth and travel to distant places wit
'/>"/>

SOURCE CureFAKtor Pharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Targeted to Protein-Protein Binding Sites Inhibit Pancreatic Cancer Cells Growth
2. CureFAKtor Pharmaceuticals Receives Orphan Drug Designation for Its Lead Compound CFAK-C4 for the Treatment of Pancreatic Cancer
3. MAP Pharmaceuticals to Present Data on LEVADEX® at the 15th Congress of the International Headache Society
4. Radient Pharmaceuticals Corporation Joins OTCQX
5. Vista Partners Initiates Coverage on ADVENTRX Pharmaceuticals, Inc.; Target Price $7.50
6. Cempra Pharmaceuticals to Present at the 2011 Wells Fargo Healthcare Conference
7. Alder Biopharmaceuticals to Receive $15 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2b Clinical Trial in Rheumatoid Arthritis of ALD518/BMS-945429 Antibody Therapeutic Against IL-6
8. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets
9. Omthera Pharmaceuticals, Inc. to Present at the 2011 Wells Fargo Securities Healthcare Conference
10. Access Pharmaceuticals Receives Letter of Acceptance For MuGard Filing From SFDA of China
11. Cubist Pharmaceuticals Applauds Congressman Gingrey for Introducing Legislation to Help Fight Superbug Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... -- In what is a first formal tie-up for the ... research organization -- are co-organizing the BPMDS Symposium China ... the MEDTEC China South 2015 exhibition at Shenzhen Convention & ... Chinese medical device manufacturers in going abroad. This ... in China . Furthermore, MEDTEC China South ...
(Date:4/1/2015)...  Medelita® has renewed a commitment to identify top ... who have exhibited leadership in their communities and ... year, "The Right Fit H.E.R.O. Honorarium" saw over 200 ... to 10 through a series of criteria, including an ... colleagues in medicine, friends, and family.  In its second ...
(Date:4/1/2015)... , Mar. 30, 2015 Research and ... the addition of the "Medical Device Studies: ... This course has been designed specifically for ... required for medical devices and in-vitro diagnostic products. ... and the emphasis on high quality, appropriate clinical ...
Breaking Medicine Technology:MEDTEC & NAMSA Co-organize BPMDS Symposium China 2MEDTEC & NAMSA Co-organize BPMDS Symposium China 3Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 2Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 3Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 4Medical Device Studies: Clinical Evidence Seminar - London, UK, 13th, 14th of May 2015 2
... Handa Pharmaceuticals, LLC ("Handa"), a specialty pharmaceutical ... its Abbreviated New Drug Application ("ANDA") for Dexlansoprazole ... of Takeda,s DEXILANT®, has been accepted for review ... Based upon available information, Handa believes that it ...
... SAN MATEO, Calif., March 2, 2011 Nile Therapeutics, ... on the development of novel therapeutics for heart failure ... Company received a positive determination from the NASDAQ Listing ... granted the Company,s request for an extension to remain ...
Cached Medicine Technology:Handa Pharmaceuticals Announces Submission of Its First-to-File ANDA for Takeda's DEXILANT® 2Nile Therapeutics Receives Positive NASDAQ Panel Decision 2Nile Therapeutics Receives Positive NASDAQ Panel Decision 3
(Date:4/1/2015)... OSF Saint Paul Medical Center, the ... was welcomed into the Ministry April 1, 2015, with ... E. Showalter, vicar general of the Catholic Diocese of ... a nearly year-long transition process for the former Mendota ... for the morning ceremony included Sister Judith Ann Duvall, ...
(Date:4/1/2015)... 01, 2015 South Florida’s newest concept ... of Authority (PCOA) approval from the State of Florida. ... ongoing development of a retirement community that will offer ... and spiritual development. , America’s aging population is experiencing ... housing needs of seniors, according to a recent report ...
(Date:4/1/2015)... 2015 Aging2.0 , the global ... the launch of the Aging2.0 Alliance – ... and technology companies. The announcement was made today at ... Business Strategies Forum in San Diego, CA. ... program is now open for additional members. “This is ...
(Date:4/1/2015)... 01, 2015 eMindful , the ... of its executive team with the addition of veteran ... , In his new role, Suissa is ... interface across the business and consumer portals. He also ... the company’s online community. His hiring was a ...
(Date:4/1/2015)... Dallas, Texas (PRWEB) April 01, 2015 ... surgeon and Distinguished Teaching Professor of the Department ... joined with other doctors to review reports of blindness ... in cosmetic surgery . The group published their study, ... Plastic and Reconstructive Surgery journal. , "We began to ...
Breaking Medicine News(10 mins):Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 3Health News:Casa Sant’Angelo Receives Approval for New Retirement Living 2Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 2Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 4Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 2Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 3Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 3
... Scientists have identified the receptor in cells of the peripheral ... to sense cold. ,The finding, reported on-line ... the key mechanisms by which the body detects temperature sensation. ... mediates how the body experiences intense stimuli temperature, in ...
... (FDA) today approved Torisel (temsirolimus) for the treatment of a ... carcinoma. Torisel was approved based on a study that ... renal cell carcinoma. The drug is an enzyme inhibitor, a ... ,'We have made significant advances in the battle ...
... is only a pretext for multinational corporations to take control ... in US charge. With sales of over $35 billion ... it takes to buy up pristine springs in some of ... Nestl, which controls one-third of the U.S. market and sells ...
... combined with sulphur to improve its overall strength and durability. ... to reform and reuse old tyres. The only way ... a process that releases heavy metals and other pollutants and ... and colleagues at Swansea University, UK, have shown that spinning ...
... will have a new -- virtually pain free -- ... Health System (SJMHS) announced today it will begin treating ... Wednesday, June 6th. ,This advanced radiosurgery system ... previously inoperable tumors, with astounding accuracy and with little ...
... to emergency needs and low donor turnout. The American Red ... can, to donate blood. ,As of this ... Red Cross had no units of Type O-negative -- the ... below a one-day supply. ,Shortages of Type O-negative ...
Cached Medicine News:Health News:Detecting Cold, Feeling Pain: Study Reveals Why Menthol Fresh 2Health News:Detecting Cold, Feeling Pain: Study Reveals Why Menthol Fresh 3Health News:FDA: New Drug for Advance Kidney Cancer 2Health News:Multinationals Exploit Groundwater Sources, and People Suffer 2Health News:Multinationals Exploit Groundwater Sources, and People Suffer 3Health News:Multinationals Exploit Groundwater Sources, and People Suffer 4Health News:Multinationals Exploit Groundwater Sources, and People Suffer 5Health News:Advanced Cancer Treatment Brings New Hope to Michigan Patient 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: